ClinicalTrials.Veeva

Menu

the Real-world Data of Risk Factor and Its Prognosis in PREmature Coronary ARtery DIseAse Study (PRE-CARDIA)

Sun Yat-sen University logo

Sun Yat-sen University

Status

Active, not recruiting

Conditions

Premature Coronary Heart Disease

Treatments

Behavioral: physical activity

Study type

Observational

Funder types

Other

Identifiers

NCT06695182
PRE-CARDIA study

Details and patient eligibility

About

The goal of this observational study is to explore the relationship between biological aging and long-term prognosis of patients with metabolic cardiovascular disease in premature coronary artery disease. The main question[s] it aims to answer [is/are]:

  1. Do patients with premature coronary heart disease have accelerated biological aging?
  2. What is the prognosis of accelerated biological aging in patients with premature coronary heart disease?

Enrollment

3,000 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or female inpatients over 18 years old in the Department of Cardiovascular Medicine;
  • Patients with one of the following metabolic cardiovascular diseases [17]: including diabetes, hypertension, coronary heart disease, heart failure, cerebral infarction, dyslipidemia, obesity and hyperuricemia;
  • Those who have corresponding inspection data so as to be able to calculate the biological age;
  • Obtaining oral informed consent or signing an informed consent form;

Exclusion criteria

·NA

Trial design

3,000 participants in 1 patient group

premature coronary artery disease
Treatment:
Behavioral: physical activity

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems